References

Allergen immunotherapy: the evidence supporting the efficacy and safety of subcutaneous immunotherapy and sublingual forms of immunotherapy for allergic rhinitis/conjunctivitis and asthma

10.1016/j.jaip.2024.04.034 · 2024 · External reference

Mechanisms and predictive biomarkers of allergen immunotherapy in the clinic

10.1016/j.jaip.2023.11.027 · 2024 · External reference

Allergen immunotherapy for asthma

10.1016/j.jaip.2023.11.031 · 2024 · External reference

Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: an EAACI Position Paper

10.1111/all.13138 · 2017 · External reference

Current advances in house dust mite allergen immunotherapy (AIT): routes of administration, biomarkers and molecular allergen profiling

10.1016/j.molimm.2023.02.004 · 2023 · External reference

Immune signatures predict response to house dust mite subcutaneous immunotherapy in patients with allergic rhinitis

10.1111/all.16068 · 2024 · External reference

Early changes in house dust mite component specific immunoglobulin levels predict the one-year efficacy of allergen immunotherapy in patients with allergic rhinitis

10.1002/clt2.70099 · 2025 · External reference

Cytokines and immunologic checkpoint molecules in predicting success of allergen immunotherapy

10.1038/s41598-026-53894-6 · 2026 · External reference

Local specific IgE levels can predict and monitor the therapeutic response to subcutaneous immunotherapy with house dust mite

10.1002/alr.70098 · 2026 · External reference

Nasal allergen-neutralizing antibodies correlate closely with tolerated intranasal allergen challenge dose following grass pollen subcutaneous immunotherapy in patients with local allergic rhinitis

10.1111/all.16083 · 2024 · External reference

Cross-protection of allergen immunotherapy-induced antibodies to related allergens requires a high degree of structural identity

10.1111/all.16323 · 2025 · External reference

Functional rather than immunoreactive levels of IgG4 correlate closely with clinical response to grass pollen immunotherapy

10.1111/j.1398-9995.2011.02745.x · 2012 · External reference

The IgE-facilitated allergen binding (FAB) assay: validation of a novel flow-cytometric based method for the detection of inhibitory antibody responses

10.1016/j.jim.2006.09.004 · 2006 · External reference

Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies

10.1016/j.jaci.2010.12.1080 · 2011 · External reference

Sustained effect of grass pollen subcutaneous immunotherapy on suppression of allergen-specific basophil response; a real-life, nonrandomized controlled study

10.1111/all.12581 · 2015 · External reference

Peripherally induced RORγt+ skin-resident regulatory T cells mediate the efficacy of allergen-specific immunotherapy

10.1126/scitranslmed.ado1375 · 2025 · External reference

Circulating type 2 memory B cell frequency is a biomarker for allergen immunotherapy efficacy in patients with allergic rhinitis

10.1111/all.70221 · 2026 · External reference

10.1097/cm9.0000000000004189 · 2026 · Admitted local publication

Booster injection with birch pollen extract activates B-cellular memory responses in patients having completed allergen immunotherapy

10.1002/eji.70034 · 2025 · External reference

Multiomics approaches disclose very-early molecular and cellular switches during insect-venom allergen-specific immunotherapy: an observational study

10.1038/s41467-024-54684-2 · 2024 · External reference

Multiomics approach to evaluating personalized biomarkers of allergen immunotherapy

10.1016/j.jaci.2025.06.036 · 2025 · External reference

Personalized medicine for allergy treatment: allergen immunotherapy still a unique and unmatched model

10.1111/all.14575 · 2021 · External reference

Biomarkers and immune cells in allergen-specific immunotherapy: toward objective evaluation

10.15586/aei.v54i2.1533 · 2026 · External reference

Recent advances in biomarkers for efficacy assessment in allergen-specific immunotherapy

10.3389/falgy.2026.1793591 · 2026 · External reference